Data protection Impressum

Newsroom

ImmuniWeb, a Geneva-based cybersecurity provider, has opened regional offices in London, Washington, and Dubai to enhance support for its global clientele, following record growth and increased demand for its AI-driven security solutions.

Geneva’s ImmuniWeb expands to London, Washington and Dubai following record growth

4 November 2024

The 2024 MassChallenge Switzerland Awards recognized four Swiss start-ups among its top winners, including EPFL spin-off Myriad Optics, which received the CHF 80,000 Platinum Award for its pathogen detection technology.

MassChallenge Switzerland 2024 Awards recognizes innovative Western Switzerland start-ups

4 November 2024

PeriVision, a Bern-based start-up, has received CE Marking for its VisionOne device, allowing it to be sold throughout Europe.

PeriVision receives CE marking for its VisionOne glaucoma diagnostics device

4 November 2024

The University of Neuchâtel has inaugurated a new solar roof at its Faculty of Economics, merging state-of-the-art solar technology with heritage preservation, furthering the canton’s 2050 climate goals.

The University of Neuchâtel unveils a solar roof that merges innovation with heritage preservation

30 October 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

Distalmotion has received FDA approval for its Dexter Surgical Robot, allowing it to enter the U.S. outpatient market.

Distalmotion secures FDA approval for its Dexter surgical robot

29 October 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (October 2024)

29 October 2024

ATANIS Biotech, a leader in allergy diagnostics, has raised capital to advance its novel allergy test, FAST-PASE.

ATANIS Biotech secures new funding to launch its FAST-PASE allergy diagnostic test

28 October 2024

ONWARD Medical has raised EUR 50 million through an upsized private placement, establishing a strategic partnership with Ottobock. The funds will drive ONWARD’s research and commercialization of spinal cord therapies, with plans for collaboration with Ottobock on future innovations.

ONWARD Medical raises EUR 50 million and welcomes a new strategic partner

28 October 2024

Three Geneva-based start-ups - Dyneo Technologies, Adoram Therapeutics and ex vivo - have received CHF 250,000 from the FONGIT Innovation Fund to advance solutions in cleantech, life sciences and virtual reality.

Three innovative Geneva-based start-ups receive FIF funding

28 October 2024

1 … 28 29 30 31 32 33 34 35 36 … 153